ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2020
Funding rounds raised
V
ViroCell Biologics raised undisclosed on September 14, 2024
Investors: First Light Asset Management and + 1 Other investor